Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cance... (30th Annual San Antonio Breast Cancer Sy...)

Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients

Date:10/11/2007

30th Annual San Antonio Breast Cancer Symposium, December 12 - 16.

About Oncotype DX(TM)

Oncotype DX is the first multi-gene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of breast cancer recurrence, the likelihood of breast cancer survival and the likelihood of chemotherapy benefit in women with estrogen receptor-positive, node-negative, tamoxifen-treated breast cancer. Oncotype DX has been extensively evaluated in multiple independent studies involving more than 2,600 breast cancer patients, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. As of June 30, 2007, over 6,000 physicians have ordered a cumulative total of more than 33,000 tests and the test is now covered by reimbursement contracts and agreements with health plans covering approximately 145 million lives. For more information about Oncotype DX, please visit http://www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit

SOURCE Genomic Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference
2. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
8. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
9. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
10. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
11. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke

Post Your Comments:

(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportl...ort is available in its catalogue. ,, Global S...sing Adoption to Drive Growth ,, http://www....lood-Glucose-Market-(SMBG )-Increasing-Adoption-to...edium=pr&utm_campaign=prnewswire ,, Descr...

(Date:11/20/2009)... , NEW YORK, Nov. 20 Reportl...ort is available in its catalogue. ,, Medical ... http://www.reportlinker.com/p0164242/Medical-Ad..._source=prnewswire&utm_medium=pr&utm_campa...s and sealants is gaining preeminence in medical d...

(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-Firs...: BDX ) today announced the completion of its ac...n-based company that develops and manufactures mol... ,, In May 2009, BD and HandyLab announced an e...lize molecular assays on the HandyLab Jaguar(TM) p...

[0] Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth [0] Reportlinker Adds Medical Adhesives and Sealants - A US Market Review [0] BD Completes Acquisition of HandyLab, Inc.

...t. 30 Emphasys Medical, Inc.,today announced that...,Zephyr(R) Endobronchial Valve (EBV) has been acce...rug Administration (FDA) and has been granted,expe...ve treatment option,intended to help patients with...pedited review based on the potential of endobronc...

...Hospital-Wide View of MRSA Infections, DUBLIN, Oh... products and services that improve the safety and...w service to help,hospitals combat methicillin-res...t are responsible for an estimated 94,000 life-thr...the U.S.(1) Cardinal Health is deploying a new MR...

Other Medicine Technology:Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 2 Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve 3 Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 2 Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals 3

Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals

(Date:11/21/2009)..., WASHINGTON, Nov. 21 ...ment after the Senate voted to begin full debate o...o: http://www.newscom.com/cgi-bin/prnh/20080519/D...istoric step on the road to enacting health insura...le, senators will now have an opportunity to debat...

(Date:11/21/2009)..., NEW YORK, Nov. 21 Milvia Lopez...York City, recently filed suit, in Supreme Court, ...complaint alleges that while Ms. Lopez underwent a... ST. VINCENT,S HOSPITAL , doctors used an HIV inf...aint alleges that several hours after being discha...

(Date:11/21/2009)..., Association Discusses Key Provisions of Legis... Reform ,, ST. CHARLES, Ill., Nov. 21 /PRNewsw...entatives passing the landmark Affordable Health C...ving key health reform legislation forward, Congre...oken health care system. Today, AARP hosted an ed...

(Date:11/21/2009)... NH based medical credentialing s...its industry to form a partnerhsip with Amerinet, ...his partnership will help to transform quality car... (Vocus) November 21, 2009 -- ISG Group, L...nced a new agreement with Amerinet Inc., a leading...

(Date:11/21/2009)... HAPPYneuron,s most popular and a... iPhone and iPod Touch. , ...PPYneuron,s most popular and addictive game, Split...ch. Split Words is designed to help banish that ,t...Words iPhone brain game challenges the brain by ...

Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2 Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2 Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2 Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2 Health News:HAPPYneuron releases iPhone Brain Game 2 Health News:HAPPYneuron releases iPhone Brain Game 3

[0] Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation [0] Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure [0] AARP Hosts Rep. Bill Foster In Health Care Reform Forum [0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care [0] HAPPYneuron releases iPhone Brain Game

... found out a new treatment “target” to help millio...ported //following their research on certain white... cause of symptoms experienced by asthma patients....ts in the Oct. 31, 2006, edition of the Proceeding...

...IDS disaster and should get a control over the HIV...t of control //warned Ashok Alexander, the directo...ior United Nations official. According to Ash... in more than 100 districts in which the foundatio...

... (WHO) reported on Monday that millions of newborn...frica from preventable diseases in spite of promis...ountries. The WHO reported that because of AID...to the WHO African countries accounted for 19 of t...

...radiographers at seven district health boards (DHB...to work with their dispute over pay parity still u...ator of contingency planning for the DHBs, said th... booked and we will be back to normal." Howeve...

...r from allergy to grass pollen will now benefit fr...uced, tablet based //vaccine named Grazax? is bein... focusing on allergy treatment. Allergy from gr...t over 45 million Europeans suffer from this aller...

...cancer-killing abilities of existing cancer drugs?...RTC-NCI-AACR symposium on Molecular Targets and Ca...uded that the answer is “yes.” These findings may ...orm in the tissues of the lung. The research...

Other Medicine News:Health News:Scientists Pursue New Treatment For Asthma Sufferers 2 Health News:Scientists Pursue New Treatment For Asthma Sufferers 3 Health News:India warned of Impending AIDS Disaster 2 Health News:WHO Attributes Death of Millions in Africa to Treatable diseases 2 Health News:Radiographers Pay Parity Disputes Still Unresolved 2 Health News:Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs 2

Scientists Pursue New Treatment For Asthma Sufferers India warned of Impending AIDS Disaster WHO Attributes Death of Millions in Africa to Treatable diseases Radiographers Pay Parity Disputes Still Unresolved Vaccine against grass pollen allergy introduced by ALK-Abell Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs

...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...

Medicine Products:

Human Monocytic Ehrlichiosis (HME), HME Antibody IgG Human Immunodeficiency Virus 1, Genotyping Human Immunodeficiency Virus 1 RNA Quantitative PCR with Reflex to Ultrasensitive RNA Quantitative PCR Human Immunodeficiency Virus 1 Antibody Confirmation by IFA

Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cance...(30th Annual San Antonio Breast Cancer Sy...),Health